Sarimo, Simo
Pajulammi, Hanna
Jämsen, Esa
Article History
Received: 3 January 2020
Accepted: 4 March 2020
First Online: 26 March 2020
Compliance with ethical standards
:
: HP has received lecture fees (unrelated to the present study) from Boehringer Ingelhelm and Orion Pharma. EJ has received lecture fees (unrelated to the present study) from Novartis, Orion Pharma, and Finnish societies of medical professionals.
: The institutional reviews board of Tampere University Hospital approved the study (R19512). Because this is a retrospective register-based study, approval from ethics committee is not required according to EU and national legislation.
: Informed consent is not required according to EU and national legislation.